Sinopharm Group (OTCMKTS:SHTDF) Stock Price Passes Below Two Hundred Day Moving Average – Should You Sell?

Sinopharm Group Co. Ltd. (OTCMKTS:SHTDFGet Free Report) crossed below its two hundred day moving average during trading on Friday . The stock has a two hundred day moving average of $2.52 and traded as low as $2.30. Sinopharm Group shares last traded at $2.30, with a volume of 1,600 shares changing hands.

Sinopharm Group Trading Down 14.0%

The firm has a fifty day simple moving average of $2.64 and a two-hundred day simple moving average of $2.52.

About Sinopharm Group

(Get Free Report)

Sinopharm Group Co, Ltd is one of China’s largest state-owned integrated healthcare companies, primarily focused on the research, development, production and distribution of a broad range of pharmaceutical and healthcare products. Established in 1998 through the reorganization of assets under China National Pharmaceutical Group (Sinopharm), the company has grown to encompass multiple business segments, including prescription medicines, over-the-counter drugs, vaccines and medical devices. Sinopharm Group is listed on the Hong Kong Stock Exchange and trades in the United States through its OTCMKTS ticker SHTDF.

The company’s product portfolio spans chemically synthesized drugs, biologics and traditional Chinese medicine formulations, supported by an extensive nationwide manufacturing and quality-control network.

Recommended Stories

Receive News & Ratings for Sinopharm Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sinopharm Group and related companies with MarketBeat.com's FREE daily email newsletter.